Comparing a PD-L1 inhibitor plus chemotherapy to chemotherapy alone in neoadjuvant therapy for locally advanced ESCC: a randomized Phase II clinical trial : A randomized clinical trial of neoadjuvant therapy for ESCC.
Li Y, Zhou A, Liu S, He M, Chen K, Tian Z, Li Y, Qin J, Wang Z, Chen H, Tian H, Yu Y, Qu W, Xue L, He S, Wang S, Bie F, Bai G, Zhou B, Yang Z, Huang H, Fang Y, Li B, Dai X, Gao S, He J.
Li Y, et al. Among authors: yang z.
BMC Med. 2023 Mar 8;21(1):86. doi: 10.1186/s12916-023-02804-y.
BMC Med. 2023.
PMID: 36882775
Free PMC article.
Clinical Trial.